Nitrate - Clopidogrel - Acute Coronary Syndrome
NCT06878638 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2025-03-17
Summary
This study aims to investigate whether intravenous nitrate given during non-ST-elevation myocardial infarction (non-STEMI) affects the platelet inhibition of clopidogrel.
Conditions
- Acute Coronary Syndromes
Sponsors & Collaborators
-
Bursa Postgraduate Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-02-01
- Primary Completion
- 2024-01-01
- Completion
- 2024-04-01
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Clopidogrel to Prasugrel in Acute Coronary Syndrome (ACS) Patients
NCT01115738 ·Status: COMPLETED ·Phase: PHASE2
-
Patent Versus Generic Clopidogrel in Acute Coronary Syndrome
NCT02628587 ·Status: UNKNOWN ·Phase: PHASE4
-
Clopidogrel Response Evaluation and AnTi-Platelet InterVEntion in High Thrombotic Risk PCI Patients
NCT01779401 ·Status: COMPLETED ·Phase: NA
-
Prasugrel 5mg Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Aged ≥75 Years and/or Weighing <60 kg Post Percutaneous Coronary Intervention (PCI)
NCT01463150 ·Status: COMPLETED ·Phase: PHASE4
-
Influence of Varenicline on the Antiplatelet Action of Clopidogrel
NCT01308671 ·Status: UNKNOWN ·Phase: NA
-
The Effect on Blood Cells, Known as Platelets, Using Prasugrel vs Clopidogrel in Patients With the Heart Problem Acute Coronary Syndrome (ACS)
NCT00385944 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Effect & Safety of Clopidogrel Napadisilate With Clopidogrel Bisulfate in Coronary Artery Disease Patients
NCT01830491 ·Status: COMPLETED ·Phase: PHASE4
-
A Comparison of Antiplatelet Therapies in Asian Subjects With Acute Coronary Syndrome
NCT00830960 ·Status: COMPLETED ·Phase: PHASE3
-
Clopidogrel High Dose Evaluation for the Patient With Coronary Artery Disease in Japan
NCT01069302 ·Status: COMPLETED ·Phase: PHASE4
-
Therapy With High Clopidogrel Dose or Prasugrel Standard Dose Reduces the Platelet Reactivity in Patients With Genotype Variation RESET GENE Trial
NCT01465828 ·Status: COMPLETED ·Phase: PHASE3
-
Point-of-Care Measurements of Platelet Inhibition After Clopidogrel Loading in Patients With Acute Coronary Syndrome: Comparison of Generic Clopidogrel Bisulfate (Plavitor®) With Original Clopidogrel Bisulfate (Plavix®)
NCT02060786 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Ticagrelor vs Clopidogrel in Patients With Acute Coronary Syndrome
NCT04630288 ·Status: UNKNOWN
-
Platelet Function Assessment for Atherothrombotic Patients
NCT00513149 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Tolerability of Clopidogrel Resinate and Clopidogrel Bisulfate in Patients With Coronary Heart Disease (CHD) or CHD Equivalents
NCT00947843 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Clopidogrel Dose Adjustment According to Platelet Reactivity Monitoring in Patients With High on Treatment Platelet Reactivity Undergoing Percutaneous Coronary Intervention
NCT01505790 ·Status: COMPLETED ·Phase: PHASE3
-
Prasugrel Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Post Percutaneous Coronary Intervention (PCI).
NCT01109784 ·Status: COMPLETED ·Phase: PHASE3
-
Clopidogrel Maintaining Dosage in Acute Coronary Syndrome After Drug Eluting Stent Implantation
NCT00404053 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Amlodipine on Anti-platelet Drug Effect in Patients With Coronary Artery Disease
NCT01203696 ·Status: COMPLETED ·Phase: PHASE4
-
Platelet Function Monitoring in Patients Treated With Clopidogrel at the Time of Primary Percutaneous Coronary Angioplasty
NCT00827346 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Evaluating Additional Platelet Inhibition in Patients With High Platelet Reactivity Undergoing Percutaneous Coronary Intervention
NCT01339026 ·Status: TERMINATED ·Phase: PHASE4
-
A Prospective muLticEnter Registry in chrONic coronARy synDrOme
NCT06198673 ·Status: NOT_YET_RECRUITING
-
Effect of Prasugrel Versus Clopidogrel on Platelet Function After Bivalirudin Cessation
NCT01789814 ·Status: COMPLETED ·Phase: PHASE4
-
Dual Antiplatelet Therapy Tailored on the Extent of Platelet Inhibition
NCT00774475 ·Status: UNKNOWN ·Phase: PHASE3
-
Vasoactive and Anti-inflammatory Effects of Prasugrel in Acute Coronary Syndrome
NCT01774838 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Pharmacodynamics and Pharmacokinetics Study of Generic and Reference Clopidogrel Products
NCT02010632 ·Status: COMPLETED ·Phase: PHASE1